Russian Physicians To Visit Fox Chase Cancer Center
Viatcheslav A. Aphanasiev, M.D., an appointee to President Vladimir Putin's Healthcare Advisory Committee, leads a delegation of top research physicians from leading cancer treatment facilities in Russia on a five-day training mission at Fox Chase Cancer Center. The visit ends Friday with the signing of a memorandum of understanding establishing an ongoing formal relationship between Fox Chase and Moscow Hospital #7. This is the third visit by physicians from Russia pursuing research and clinical relationships with Fox Chase.
In November 2000, doctors from the Irkutsk Regional Oncology Center signed an agreement to create a more formal relationship with a focus on physician training and patient care. Moscow Hospital #7 will sign a similar agreement Friday that will emphasize advance training for liver cancer treatment and research. The goal of this week's visit has been to build on the program of joint research and training established in 2000. While at Fox Chase, the physicians have been learning about new cancer treatments and surgical techniques while developing collaborative research initiatives. The physicians are from the Shcehenov Moscow Medical Academy, the Irkutsk Regional Oncology Center, and Moscow Hospital #7 in Moscow.
Eight physicians, including surgical and medical oncologists, have been teamed with physicians from Fox Chase and matched by subspecialty. The visitors will be integrated into the day-to-day activities of the Fox Chase physicians including clinics, surgery, and patient observation. Making the trip from Moscow are:
- Viatcheslav A. Aphanasiev, M.D., appointee to Prime Minister Putin's Healthcare Advisory Committee, president of Moscow Hospital #7;
- Eduard I. Galperin, M.D., chief of hepatic and metabolic surgery department, I.M. Sechenov Moscow Medical Academy, Moscow Hospital #7;
- Tatiana G. Dioujeva, M.D., Ph.D., professor of liver and metabolic surgery, I.M. Sechenov Moscow Medical Academy, Moscow Hospital #7;
- Vladimir S. Ramishvily, M.D., Ph.D. vice president and chairman of Department of Surgery, chief of urology section, Moscow Hospital #7;
- Alexander N. Antonov, M.D., chief of Endoscopy section, Moscow Hospital #7;
- Natalia V. Aphanasieva, M.D.,. surgeon, OB/GYN department, I.M. Sechenov Medical Academy;
- Nikolai Minakin, M.D., chief, Surgery Department, Irkutsk Regional Oncology Center;
- Dmitry M. Ponomarenko, M.D., medical oncologist, Chemotherapy Department, Irkutsk Regional Oncology Center; and
- Olga Oleynikova, R.N., Irkutsk Regional Oncology Center.
"These cancer centers recognize the benefits of building a long-term relationship," said Paul F. Engstrom, M.D., medical director of Fox Chase's international program. "Fox Chase can benefit from collaborative research opportunities while our Russian counterparts have the opportunity to learn about new surgical and chemotherapy treatments from Fox Chase physicians. We're excited to help them." Fox Chase physicians have already made several trips to Russia to help train physicians and to advise on patient care. The base for clinical training is at Moscow Hospital #7 and Irkutsk Regional Oncology Center. In an upcoming trip, Fox Chase also hopes to align with the Blokhin Cancer Research Center, Russian Academy of Medical Sciences. Irkutsk Regional Oncology Center (IROC) is devoted solely to cancer care.
The hospital was originally built to house 100 patients, but now provides services for 367 inpatients. IROC is the only cancer center in the region, which is home to more than three million people. Irkutsk is located on the Angara River at the midpoint of the Trans Siberian Railway. Moscow Hospital #7 is a large medical institution with 2,000 hospital beds. It is affiliated with Moscow's Sechenove Medical Academy, Russia's Post-Graduate Medical Academy, and the State University of Health Ministry of the Russian Federation. The Sechenov Moscow Medical Academy is the oldest and the largest national medical higher educational institution. The Academy plays a leading role in the development of medical science and training of medical and scientific personnel. Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach.
For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.